Rie Horii

Summary

Affiliation: Cancer Institute Hospital
Country: Japan

Publications

  1. ncbi request reprint Spontaneous " healing" of breast cancer
    Rie Horii
    Department of Breast Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:140-4. 2005
  2. doi request reprint Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer
    Rie Horii
    Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 21:598-604. 2014
  3. ncbi request reprint Histological features of breast cancer, highly sensitive to chemotherapy
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 14:393-400. 2007
  4. pmc Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
    R Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Br J Cancer 97:654-8. 2007
  5. ncbi request reprint Muco-epidermoid carcinoma of the breast
    Rie Horii
    Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 56:549-53. 2006
  6. ncbi request reprint Assessment of hormone receptor status in breast cancer
    Rie Horii
    Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 57:784-90. 2007
  7. doi request reprint Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:233-41. 2010
  8. doi request reprint Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes
    Ryoichi Matsunuma
    Department of Surgery, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Int J Radiat Oncol Biol Phys 83:845-52. 2012
  9. doi request reprint High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy
    Tomo Osako
    Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:1431-8. 2010
  10. pmc Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer Sci 105:576-82. 2014

Collaborators

Detail Information

Publications49

  1. ncbi request reprint Spontaneous " healing" of breast cancer
    Rie Horii
    Department of Breast Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:140-4. 2005
    ..Healing is a phenomenon by which the intraductal component of breast cancer disappears and is replaced by fibrous tissue. Focally localized healing often prevents confirmation of the continuity of intraductal carcinoma...
  2. doi request reprint Comparison of dual-color in-situ hybridization and fluorescence in-situ hybridization in HER2 gene amplification in breast cancer
    Rie Horii
    Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 21:598-604. 2014
    ..HER2 tests are essential in invasive and metastatic breast cancer. Dual-color in-situ hybridization (DISH) is a novel genetic test, and we investigated its utility in HER2 testing in breast cancer...
  3. ncbi request reprint Histological features of breast cancer, highly sensitive to chemotherapy
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 14:393-400. 2007
    ..To establish tailor-made therapy for breast cancer, we investigated the possibility of predicting chemotherapy sensitive cases based on pre-therapeutic histological features...
  4. pmc Optimal indications of endocrine therapy alone as adjuvant systemic treatment of breast cancer
    R Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Br J Cancer 97:654-8. 2007
    ..Endocrine monotherapy may be sufficient as adjuvant treatment in the intermediate-risk patients, in which only one risk factor was present without any metastatic involvement in lymph node...
  5. ncbi request reprint Muco-epidermoid carcinoma of the breast
    Rie Horii
    Department of Breast Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 56:549-53. 2006
    ..These histological features confirmed the diagnosis as muco-epidermoid carcinoma of the breast. This is the first report of muco-epidermoid carcinoma of the breast in Japan...
  6. ncbi request reprint Assessment of hormone receptor status in breast cancer
    Rie Horii
    Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 57:784-90. 2007
    ..When assessing hormone receptors of breast cancer in routine clinical settings, it is sufficient to determine the proportion of positive cells in the entire cancer area...
  7. doi request reprint Common and discriminative clinicopathological features between breast cancers with pathological complete response or progressive disease in response to neoadjuvant chemotherapy
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 10 6, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:233-41. 2010
    ....
  8. doi request reprint Influence of lymphatic invasion on locoregional recurrence following mastectomy: indication for postmastectomy radiotherapy for breast cancer patients with one to three positive nodes
    Ryoichi Matsunuma
    Department of Surgery, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Int J Radiat Oncol Biol Phys 83:845-52. 2012
    ..The purpose of this study was to identify patient groups for whom PMRT may be indicated, focusing on varied locoregional recurrence rates depending on lymphatic invasion (ly) status...
  9. doi request reprint High-grade breast cancers include both highly sensitive and highly resistant subsets to cytotoxic chemotherapy
    Tomo Osako
    Divisions of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo, 135 8550, Japan
    J Cancer Res Clin Oncol 136:1431-8. 2010
    ..To determine the highly sensitive and highly resistant subsets to cytotoxic chemotherapy, we evaluated predictive factors for pCR and PD to NAC, and assessed the similarities in these factors...
  10. pmc Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan Department of Pathology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer Sci 105:576-82. 2014
    ..More accurate application of SN biopsy is required for patients with a preoperative diagnosis of DCIS...
  11. doi request reprint Clinical importance of estrogen receptor-beta evaluation in breast cancer patients treated with adjuvant tamoxifen therapy
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    J Clin Oncol 26:3727-34. 2008
    ..A large and systematic study is needed to address these important issues...
  12. doi request reprint Sentinel node tumour burden quantified based on cytokeratin 19 mRNA copy number predicts non-sentinel node metastases in breast cancer: molecular whole-node analysis of all removed nodes
    Tomo Osako
    Division of Pathology, The Cancer Institute of Japanese Foundation for Cancer Research, 3 8 31, Ariake, Koto ku, Tokyo 135 8550, Japan
    Eur J Cancer 49:1187-95. 2013
    ..We aim to reveal the usefulness of the OSNA assay regarding the prediction of non-SN metastasis...
  13. pmc Ductal carcinoma in situ and sentinel lymph node metastasis in breast cancer
    Keiichiro Tada
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    World J Surg Oncol 8:6. 2010
    ..The impact of sentinel lymph node biopsy on breast cancer mimicking ductal carcinoma in situ (DCIS) is a matter of debate...
  14. doi request reprint Oestrogen receptor-beta1 but not oestrogen receptor-betacx is of prognostic value in apocrine carcinoma of the breast
    Naoko Honma
    Research Team for Geriatric Diseases, Tokyo Metropolitan Institute of Gerontology, Tokyo, Japan
    APMIS 116:923-30. 2008
    ..ER-beta1 itself, independent of ER-alpha expression and tamoxifen treatment, seems to have a tumor-suppressive effect, at least in apocrine carcinomas. Further study of ER-beta1 is desired to optimize breast cancer treatment...
  15. doi request reprint Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications
    Rin Yamaguchi
    Department of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo 135 8550, Japan
    Hum Pathol 41:679-85. 2010
    ..The presence of high-grade spindle cells in metaplastic breast carcinoma may indicate aggressive behavior...
  16. doi request reprint Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital
    Akiko Ogiya
    Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 23:318-22. 2016
    ..We examined the long-term results of omission of axillary dissection in sentinel lymph node-negative patients treated at our hospital, as well as their axillary lymph node recurrence characteristics and outcomes...
  17. doi request reprint Four types of ipsilateral breast tumor recurrence (IBTR) after breast-conserving surgery: classification of IBTR based on precise pathological examination
    Takehiko Sakai
    Department of Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 65:113-8. 2015
    ..Precise pathological examinations indicated four distinct IBTR subtypes with different characteristics. ..
  18. doi request reprint Detection of occult invasion in ductal carcinoma in situ of the breast with sentinel node metastasis
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer Sci 104:453-7. 2013
    ..Patient follow-up is required to elucidate the prognostic impact of nodal metastasis and occult invasion...
  19. doi request reprint Intraoperative molecular assay for sentinel lymph node metastases in early stage breast cancer: a comparative analysis between one-step nucleic acid amplification whole node assay and routine frozen section histology
    Tomo Osako
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Cancer 117:4365-74. 2011
    ..The authors compared the performance in intraoperative detection of sentinel lymph node metastases with OSNA assay using a whole lymph node versus routine frozen section (FS) histology with a 2 mm-sectioned lymph node...
  20. doi request reprint Prospective randomized phase II study determines the clinical usefulness of genetic biomarkers for sensitivity to primary chemotherapy with paclitaxel in breast cancer
    Yoshinori Ito
    Department of Medical Oncology, Cancer Institute Hospital, Japanese Foundation for Cancer Research Breast Center, International University of Health and Welfare Mita Hospital, Tokyo, Japan
    Cancer Sci 102:130-6. 2011
    ..However, this study suggests that a randomized phase II study is a robust tool for obtaining a rapid conclusion on the usefulness of biomarkers and could be the foundation for further large clinical trials...
  21. doi request reprint Validation study of the UICC TNM classification of malignant tumors, seventh edition, in breast cancer
    Natsue Uehiro
    Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Breast Cancer 21:748-53. 2014
    ..The major change concerning breast cancer is a change in the stages for patients with T0 or T1N1miM0. In the present study, the seventh edition of the TNM classification was validated in breast cancer...
  22. doi request reprint Extensive analysis of signaling pathway molecules in breast cancer: association with clinicopathological characteristics
    Rie Horii
    Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Int J Clin Oncol 20:490-8. 2015
    ..The aim of this study was to extensively analyze the signaling pathway molecules in breast cancer and to explore candidate biomarkers for clinicopathological relevance...
  23. doi request reprint Non-sentinel lymph node analysis with one-step nucleic acid amplification in breast cancer patients
    Akiko Ogiya
    Department of Surgical Oncology, Breast Oncology Center, Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo 135 8550, Japan Electronic address
    Breast 24:476-80. 2015
    ..In this study, we conducted a whole-node analysis of non-sentinel lymph nodes (SLNs) using the OSNA method in SLN metastasis-positive breast cancer patients...
  24. pmc Clear cell sarcoma of the neck which metastasized to the mammary gland
    Ippei Fukada
    Department of Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, and the Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Case Rep Oncol 6:55-61. 2013
    ..These findings led to a diagnosis of metastasis of clear cell sarcoma to the mammary gland. This is the first report of clear cell sarcoma of the neck which metastasized to the mammary gland...
  25. doi request reprint Clinicopathological significance of invasive micropapillary carcinoma component in invasive breast carcinoma
    Yoshimi Ide
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 61:731-6. 2011
    ..The presence of IMP components was a significant predictive factor for nodal metastasis, even if it is detected in only a small proportion of the tumor...
  26. pmc Skin invasion and prognosis in node negative breast cancer: a retrospective study
    Keiichiro Tada
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo, Japan
    World J Surg Oncol 6:10. 2008
    ..The impact of skin invasion in node negative breast cancer is uncertain...
  27. doi request reprint Apocrine metaplasia of breast cancer: clinicopathological features and predicting response
    Akiko Ogiya
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, Koto ku, Tokyo, Japan
    Breast Cancer 17:290-7. 2010
    ..We thus considered that apocrine metaplasia (AM) might represent a predictive marker for breast cancer...
  28. doi request reprint Histogenesis of metaplastic breast carcinoma and axillary nodal metastases
    Tomo Osako
    Division of Pathology, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Ariake, Koto ku, Tokyo, Japan
    Pathol Int 59:116-20. 2009
    ..This suggested that the ductal component metastasized to the nodes and that epithelial-mesenchymal transition subsequently occurred within the nodes...
  29. pmc Differences in clinical importance of Bcl-2 in breast cancer according to hormone receptors status or adjuvant endocrine therapy
    Naoko Honma
    Department of Pathology, School of Medicine, Toho University, 5 21 16 Omori nishi, Ota ku, Tokyo, 143 8540, Japan
    BMC Cancer 15:698. 2015
    ..We constructed a large systematic study to determine whether Bcl-2 has an independent role in breast cancer...
  30. doi request reprint Trastuzumab Rechallenge After Lapatinib- and Trastuzumab-Resistant Disease Progression in HER2-Positive Breast Cancer
    Kazuhiro Araki
    Breast Medical Oncology, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan Breast Oncology Center, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, Tokyo, Japan Electronic address
    Clin Breast Cancer 15:432-9. 2015
    ..However, optimal management has yet to be established for lapatinib (LAP)- and trastuzumab (Tmab)-resistant disease progression. Data from our institution were reviewed to contribute to the search for best practices...
  31. doi request reprint Proportion of estrogen or progesterone receptor expressing cells in breast cancers and response to endocrine therapy
    Naoko Honma
    Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35 2 Sakaecho, Itabashi ku, Tokyo 173 0015, Japan Department of Pathology, Cancer Institute, 3 8 31 Ariake, Koto ku, Tokyo 135 8550, Japan Electronic address
    Breast 23:754-62. 2014
    ..Patients having tumors without any ER/PR-positive cells should be excluded from endocrine therapy, whereas this therapy should be strongly recommended for those with ≥67% ER/PR-positive cells. ..
  32. doi request reprint Carcinoma in a solitary intraductal papilloma of the breast
    Rin Yamaguchi
    Department of Pathology, Cancer Institute Hospital, Tokyo, Japan
    Pathol Int 59:185-7. 2009
    ..An additional partial mastectomy was performed after the lumpectomy but no carcinoma foci were noted in the excised tissue. Possible occurrence of cancerous change in solitary intraductal papilloma of the breast was suspected...
  33. doi request reprint Ki-67 evaluation at the hottest spot predicts clinical outcome of patients with hormone receptor-positive/HER2-negative breast cancer treated with adjuvant tamoxifen monotherapy
    Naoko Honma
    Research Team for Geriatric Pathology, Tokyo Metropolitan Institute of Gerontology, 35 2 Sakaecho, Itabashi ku, Tokyo, 173 0015, Japan
    Breast Cancer 22:71-8. 2015
    ..Further, Ki-67 evaluation methodology differed among studies, which prevents Ki-67 from being used for clinical practice. We performed a large systematic study using routinely processed tissues and compared various scoring methods...
  34. ncbi request reprint Intraductal papilloma with bloody discharge from Montgomery's areolar tubercle examined by ductoscopy from the areola
    Takehiko Sakai
    Breast Pathology Section, Cancer Institute, Japanese Foundation for Cancer Research, 3 10 6, Ariake, Tokyo 135 8550, Japan
    Breast Cancer 13:104-6. 2006
    ..Although there are a few breast carcinomas that cause bloody discharge and eruption of areola, areolar preservation should be performed with the knowledge that disease may also involve the areola through the lactiferous ducts...
  35. doi request reprint Breast cancer associated with mammary hamartoma
    Masaya Kai
    Department of Breast Surgery, Cancer Institute Hospital, Koto ku, Tokyo, Japan
    Breast Cancer 19:183-6. 2012
    ..We describe a case of invasive ductal carcinoma arising in the mammary hamartoma during the follow-up period of a previously diagnosed hamartoma...
  36. doi request reprint Prognostic significance of histological therapeutic effect in preoperative chemotherapy for breast cancer
    Kokoro Kobayashi
    Department of Breast Medical Oncology, Breast Oncology Center, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Pathol Int 66:8-14. 2016
    ..001). The prognosis of breast cancer patients with neoadjuvant chemotherapy can be predicted by histological therapeutic effect and staging classification of residual cancer. ..
  37. doi request reprint Lapatinib-associated mucocutaneous toxicities are clinical predictors of improved progression-free survival in patients with human epidermal growth factor receptor (HER2)-positive advanced breast cancer
    Kazuhiro Araki
    Beast Medical Oncology, Breast Oncology Center, The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 8 31 Ariake Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer Res Treat 148:197-209. 2014
    ..0011). The median PFS of patients who had all three AEs was 13.2 months, compared with 2.6 months for those who did not (p = 0.00000174). Mucocutaneous toxicities may be predictors of the response to LAP in patients with HER2ABC. ..
  38. ncbi request reprint [Evaluation of hormone receptor in breast cancers and the prognosis]
    Yuko Date
    Department of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research
    Nihon Rinsho 65:555-8. 2007
  39. pmc Proposal of a novel method for observing the breast by high-resolution ultrasound imaging: understanding the normal breast structure and its application in an observational method for detecting deviations
    Ayumi Izumori
    The Cancer Institute Hospital of the Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 20:83-91. 2013
    ..We elucidated the detailed histological architecture of the normal breast, information indispensable for diagnostic US of the breast...
  40. doi request reprint Efficacy of fulvestrant 500 mg in Japanese postmenopausal advanced/recurrent breast cancer patients and factors associated with prolonged time-to-treatment failure
    Kazuhiro Araki
    a Breast Medical Oncology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, 3 8 1 Ariake, Koto ku, Tokyo 135 8550, Japan
    Expert Opin Pharmacother 16:2561-8. 2015
    ..We aimed to confirm the efficacy of fulvestrant in Japanese postmenopausal advanced/recurrent breast cancer (ABC) patients, and investigate factors contributing to time-to-treatment failure (TTF) prolongation...
  41. ncbi request reprint A case of carcinosarcoma of the breast
    Nahomi Tokudome
    Department of Breast Pathology, The Cancer Institute, 3 10 16 Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 12:149-53. 2005
    ..Such tumors are very rare, and there have been no detailed reports of recurrence patterns of carcinosarcoma. Here we report our pathological findings in detail...
  42. ncbi request reprint Present state of and problems with core needle biopsy for non-palpable breast lesions
    Takuji Iwase
    Department of Breast Surgery, Cancer Institute Hospital, Tokyo 135 8550, Japan
    Breast Cancer 13:32-7. 2006
    ....
  43. doi request reprint Therapeutic strategies for breast cancer based on histological type
    Futoshi Akiyama
    Division of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research, 3 10 6 Ariake, Koto ku, Tokyo 135 8550, Japan
    Breast Cancer 16:168-72. 2009
    ..Histological diagnosis is also significant from the viewpoint of drug sensitivity, and it is important to maintain the accuracy of histological diagnosis...
  44. doi request reprint Development of an easy method to test for HER2 in breast cancer using dual-color in situ hybridization
    Tomoe Nakagawa
    Department of Pathology, Cancer Institute, Japanese Foundation for Cancer Research, 3 8 31 Ariake, Koto ku, Tokyo, 135 8550, Japan
    Breast Cancer 23:78-84. 2016
    ..We devised an easy method for HER2 gene testing and investigated its utility...
  45. doi request reprint A clinico-pathological study on cancer in sclerosing adenosis
    Kaoru Ogura
    Division of Pathology, Cancer Institute of Japanese Foundation for Cancer Research, Tokyo, Japan
    Breast Cancer 21:732-7. 2014
    ..This study aimed to elucidate the features of the former by comparing both types...
  46. doi request reprint Secretory carcinoma of the breast and its histopathological mimics: value of markers for differential diagnosis
    Tomo Osako
    Division of Pathology, The Cancer Institute, Japanese Foundation for Cancer Research, Tokyo, Japan Department of Pathology, The Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan
    Histopathology 63:509-19. 2013
    ..However, differential markers have not yet been assessed systematically, and we aimed to identify and evaluate novel and existing markers...
  47. ncbi request reprint [Histological features of breast cancer as predictive factors for chemotherapy]
    Rie Horii
    Department of Pathology, The Cancer Institute of the Japanese Foundation for Cancer Research
    Nihon Rinsho 65:160-4. 2007
  48. pmc Targeting MCM2 function as a novel strategy for the treatment of highly malignant breast tumors
    Shinya Abe
    Department of Comprehensive Pathology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, Tokyo, Japan
    Oncotarget 6:34892-909. 2015
    ..Therefore, an MCM2-targeted strategy using Hph-1-gp70 treatment to induce DNA damage might be a successful therapy for highly malignant breast cancers such as TNBC and for the eradication of CSC-like cells from breast cancer tissue...
  49. ncbi request reprint High prevalence of HER-2/neu and p53 overexpression in inflammatory breast cancer
    Masataka Sawaki
    Department of Medical Oncology, Cancer Institute Hospital and Cancer Chemotherapy Center, Japanese Foundation for Cancer Research
    Breast Cancer 13:172-8. 2006
    ..We have summarized a single-center experience involving IBC patients. Our objectives are to clarify molecular alterations of HER-2/neu and p53 in IBC and to investigate the prognostic factors...